Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MAL |
| Upstream (Parents) |
|---|
| (<<) XCL2///XCL1 → MAL |
| (<<) KRT13 → MAL |
| (<<) FAM65B → MAL |
| (<<) S100A9 → MAL |
| (<<) CSTA → MAL |
| (<<) TMPRSS11D → MAL |
| (<<) AHCYL2 → MAL |
| Downstream (Children) |
|---|
| MAL → KRT13 (>>) |
| MAL → GIF (>>) |
| MAL → OR2B2 (>>) |
| MAL → C16orf3 (>>) |
| MAL → MT4 (>>) |
| MAL → CNGB3 (>>) |
